SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Datsons moves higher on inking MoU with AL-Mugdh Pharma

02 Mar 2015 Evaluate

Dr. Datasons Labs is currently trading at Rs. 6.83, up by 0.13 points or 1.94% from its previous closing of Rs. 6.70 on the BSE.

The scrip opened at Rs. 6.75 and has touched a high and low of Rs. 6.85 and Rs. 6.74 respectively. So far 125027 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.80 on 10-Mar-2014 and a 52 week low of Rs. 6.03 on 25-Feb-2015.

Last one week high and low of the scrip stood at Rs. 7.60 and Rs. 6.03 respectively. The current market cap of the company is Rs. 74.52 crore.

The institutions and non-institutions held 38.87% and 61.13% stake in the company, respectively.

Dr. Datsons Labs and AL-Mugdh Pharma of Yemen have signed a licensing, distribution and supply deal, under which the distribution company will market Anti-Malarial Drugs. The company is also looking to widen its product basket to cater to the regulated & semi regulated market.

Dr. Datsons Labs is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

 

Peers
Company Name CMP
Sun Pharma Inds. 1675.80
Dr. Reddys Lab 1228.70
Cipla 1237.45
Zydus Lifesciences 944.45
Lupin 2313.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×